Future of pharma's commercial model | Deloitte Insights
The biopharmaceutical industry’s commercial model has been an important part of each company’s success, but the current capabilities and strategies are unlikely to suffice for future …
Trust in biopharma during COVID-19 | Deloitte Insights
May 6, 2021 · Consumers may appreciate pharma companies’ efforts to speed up the process of bringing COVID-19 vaccines to market. How might biopharma continue to innovate while …
AI In Biopharma Collection | Deloitte Insights
Artificial intelligence-enabled technologies are transforming the different parts of the biopharma industry value chain, creating new business opportunities. Explore Deloitte's collection of …
Deloitte US | Together Makes Progress
Discover industry insights and audit, tax, and consulting services that drive impact from Deloitte’s global network of member firms.
Inorganic growth activity in life sciences— have we reached the bottom? Our previous report outlined a steep decline in life sciences deal-making in the first half of 2022 from record levels …
バイオ医薬品における新規モダリティと周辺市場の形成 | デロイ …
Apr 10, 2024 · バイオ・創薬スタートアップは新規モダリティの創出の原動力であり、ひとたび新規モダリティが上市されると、それらは大きな市場を形成し、同時に業界構造についても …
Deloitte US | Audit, Consulting, Advisory, and Tax Services
Deloitte US | Audit, Consulting, Advisory, and Tax Services
2025年度版「グローバル自動車消費者意識調査」 | デロイト トー …
2024年10月から11月にかけて実施された2025年度版グローバル自動車消費者調査では、次の4つの主要なトレンド取り上げる。 ほとんどの市場でバッテリー式電気自動車（BEV）への関 …
More than 3/4 of biopharma companies agree that their organizations need new leaders to succeed in the digital age. Many companies are recruiting outside of life sciences for digital …
Business insights, analysis & perspectives | Deloitte Insights
Deloitte Insights delivers research, analysis, and perspectives for business and government.